213 AZACITIDINE (AZA) IN HIGHER RISK MDS PATIENTS WITH CHROMOSOME 7 ABNORMALITIES (ABN 7): RESULTS OF A RETROSPECTIVE STUDY FROM THE GFM AND GESMD REGISTRIES

Autor:	Campelo, M. Díez, Lorenzo, J.I., Itzykson, R., Rojas, S.M., Berthon, C., Luño, E., Beyne-Rauzy, O., Pérez-Oteyza, J., Vey, N., Bargay, J., Park, S., Cedena, T., Bordessoule, D., Muñoz, J.A., Gyan, E., Such, E., Visanica, S., Benlloch, L., de Botton, S., Hernández-Rivas, J.M., Ame, S., Stamatoullas, A., Delaunay, J., Salanoubat, C., Isnard, F., Guieze, R., Sanz, G., Cañizo, M.C., Fenaux, P.
Zdroj:	In Leukemia Research April 2015 39 Supplement 1:S107-S107
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect